Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Go Kaneko

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
BJUI Compass|February 19, 2024
New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinomaTakafumi Saito, Kent Kanao, Kazuhiro Matsumoto, et al.
Japanese Journal of Clinical Oncology|May 8, 2019
Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapyGo Kaneko, Suguru Shirotake, Koshiro Nishimoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 7, 2022
Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancerNishimoto Koshiro, Kenichi Nakajima, Masafumi Oyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 10, 2025
Patient Preferences for Post-Radical Cystectomy Treatment in Muscle-Invasive Bladder Cancer: A Discrete Choice Experiment in JapanShugo Yajima, Shinro Hata, Naoya Masumori, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
BJUI Compass|February 19, 2024
New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinomaTakafumi Saito, Kent Kanao, Kazuhiro Matsumoto, et al.
Japanese Journal of Clinical Oncology|May 8, 2019
Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapyGo Kaneko, Suguru Shirotake, Koshiro Nishimoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 7, 2022
Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancerNishimoto Koshiro, Kenichi Nakajima, Masafumi Oyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 10, 2025
Patient Preferences for Post-Radical Cystectomy Treatment in Muscle-Invasive Bladder Cancer: A Discrete Choice Experiment in JapanShugo Yajima, Shinro Hata, Naoya Masumori, et al.
Pageof 4